French National Observatory of Patients With Thymic Epithelial Tumor

Launched by INTERGROUPE FRANCOPHONE DE CANCEROLOGIE THORACIQUE · Mar 25, 2016

Keywords

ClinConnect Summary

The French National Observatory of Patients With Thymic Epithelial Tumor, also known as the RYTHMIC trial, is a nationwide study focused on understanding and improving the care of patients with thymic epithelial tumors, which are a type of tumor found in the thymus gland. The goal of this trial is to connect different regional expert centers across France to ensure that patients receive the best possible management and treatment through discussions held at a national tumor board.

If you have been diagnosed with a thymic epithelial tumor, you might be eligible to participate in this trial. The study is currently looking for patients aged 65 to 74, but it is open to all genders. Participants can expect to be part of a network that aims to improve treatment strategies and share valuable information about their condition. It’s important to note that only patients with thymic epithelial tumors can join, meaning those with different types of tumors would not qualify. This trial represents a valuable opportunity for patients to contribute to a better understanding of their condition while receiving expert care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patient with Thymic Epithelial Tumors
• Exclusion Criteria:
• • histology other than Thymic Epithelial Tumors